{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:50:16Z","timestamp":1788461416860,"version":"build-2803163510"},"reference-count":142,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ncl.2018.01.001","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T22:14:44Z","timestamp":1523484884000},"page":"275-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Nature and Action of Antibodies in Myasthenia Gravis"],"prefix":"10.1016","volume":"36","author":[{"given":"Robert L.","family":"Ruff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Lisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2018.01.001_bib1","first-page":"361","article-title":"The molecular biology of end-plate diseases","volume":"vol. 23","author":"Engel","year":"1987"},{"key":"10.1016\/j.ncl.2018.01.001_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0166-2236(88)90199-3","article-title":"Calcium ions, active zones and synaptic transmitter release","volume":"10","author":"Smith","year":"1988","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.ncl.2018.01.001_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1749-6632.1991.tb36505.x","article-title":"The calcium signal for transmitter secretion from presynaptic nerve terminals","volume":"635","author":"Augustine","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1749-6632.1993.tb22921.x","article-title":"Mammalian neuromuscular transmission blocked by funnel web toxin","volume":"681","author":"Protti","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1113\/jphysiol.1983.sp014492","article-title":"Electrophysiological and chemical determination of acetylcholine release at the frog neuromuscular junction","volume":"334","author":"Miledi","year":"1983","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1991.tb36484.x","article-title":"Endoplasmic reticulum as a source of Ca2+ in neurotransmitter secretion","volume":"635","author":"Etcheberrigaray","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1098\/rspb.1979.0070","article-title":"Estimates of quantal content during chemical potentiation of transmitter release","volume":"205","author":"Katz","year":"1979","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1073\/pnas.81.5.1594","article-title":"Diffusion and binding constants for acetylcholine derived from the falling phase of miniature endplate currents","volume":"81","author":"Land","year":"1984","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2018.01.001_bib9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1113\/jphysiol.1973.sp010248","article-title":"The binding of acetylcholine to receptors and its removal from the synaptic cleft","volume":"231","author":"Katz","year":"1973","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/271172a0","article-title":"Cholinesterase is associated with the basal lamina at the neuromuscular junction","volume":"271","author":"McMahan","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2018.01.001_bib11","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1073\/pnas.78.11.7200","article-title":"Kinetic parameters for acetylcholine interaction in intact neuromuscular junction","volume":"78","author":"Land","year":"1981","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2018.01.001_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1985.sp015912","article-title":"Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate","volume":"369","author":"Colquhoun","year":"1985","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib13","series-title":"Handbook of physiology","first-page":"381","article-title":"Pharmacological investigations of excitation-contraction coupling","author":"Caputo","year":"1983"},{"key":"10.1016\/j.ncl.2018.01.001_bib14","first-page":"157","article-title":"Mammalian muscle fiber types: comparison of excitation-contraction coupling mechanisms","volume":"128","author":"Donaldson","year":"1986","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.ncl.2018.01.001_bib15","first-page":"257","article-title":"Excitation-contraction coupling in skeletal muscle","volume":"vol. 1","author":"Beam","year":"2004"},{"key":"10.1016\/j.ncl.2018.01.001_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/dev.038711","article-title":"To build a synapse: signaling pathways in neuromuscular junction assembly","volume":"137","author":"Wu","year":"2010","journal-title":"Development"},{"key":"10.1016\/j.ncl.2018.01.001_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1023\/B:NEUR.0000020618.65271.63","article-title":"Signaling complexes for postsynaptic differentiation","volume":"32","author":"Luo","year":"2003","journal-title":"J\u00a0Neurocytol"},{"key":"10.1016\/j.ncl.2018.01.001_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/377232a0","article-title":"Failure of postsynaptic specialization to at neuromuscular junctions of rapsyn-deficient mice","volume":"377","author":"Gautam","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2018.01.001_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0092-8674(00)81253-2","article-title":"Defective neuromuscular synaptogenesis in agrin-deficient mutant mice","volume":"85","author":"Gautam","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ncl.2018.01.001_bib20","series-title":"Disorders of voluntary muscle","first-page":"103","article-title":"The extracellular matrix of skeletal muscle","author":"Holland","year":"2001"},{"key":"10.1016\/j.ncl.2018.01.001_bib21","series-title":"Disorders of voluntary muscle","first-page":"142","article-title":"The neuromuscular junction and neuromuscular transmission","author":"Vincent","year":"2001"},{"key":"10.1016\/j.ncl.2018.01.001_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1405.003","article-title":"Structural factors influencing the efficacy of neuromuscular transmission","volume":"1132","author":"Slater","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.mcn.2004.11.015","article-title":"Accumulation of Nav1 mRNAs at differentiating postsynaptic sites in rat soleus muscles","volume":"28","author":"Stocksley","year":"2005","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"10.1016\/j.ncl.2018.01.001_bib24","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1523\/JNEUROSCI.23-06-02102.2003","article-title":"Voltage-gated sodium channels and ankyrinG occupy a different postsynaptic domain from acetylcholine receptors from an early stage of neuromuscular junction maturation in rats","volume":"23","author":"Bailey","year":"2003","journal-title":"J\u00a0Neurosci"},{"issue":"21","key":"10.1016\/j.ncl.2018.01.001_bib25","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1523\/JNEUROSCI.21-21-08456.2001","article-title":"Sodium channel mRNAs at the neuromuscular junction: distinct patterns of accumulation and effects of muscle activity","volume":"21","author":"Awad","year":"2001","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.001_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1083\/jcb.140.3.675","article-title":"beta-Spectrin is colocalized with both voltage-gated sodium channels and ankyrinG at the adult rat neuromuscular junction","volume":"140","author":"Wood","year":"1998","journal-title":"J\u00a0Cell Biol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.001_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1097-0029(20000401)49:1<84::AID-JEMT9>3.0.CO;2-E","article-title":"Clustering of sodium channels at the neuromuscular junction","volume":"49","author":"Caldwell","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.ncl.2018.01.001_bib28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.410430315","article-title":"Endplate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis","volume":"43","author":"Ruff","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2008.04.038","article-title":"How myasthenia gravis alters the safety factor for neuromuscular transmission","volume":"201-202","author":"Ruff","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ncl.2018.01.001_bib30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/mus.22177","article-title":"Endplate contributions to the safety factor for neuromuscular transmission","volume":"44","author":"Ruff","year":"2011","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.001_bib31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500","author":"Wood","year":"1997","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/115.2.451","article-title":"Structure and function of neuromuscular junctions in the vastus lateralis of man. A motor point biopsy study of two groups of patients","volume":"115","author":"Slater","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.01.001_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0072-9752(07)01502-3","article-title":"Reliability of neuromuscular transmission and how it is maintained","volume":"91","author":"Slater","year":"2008","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib34","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/brain\/awl200","article-title":"Pre- and post-synaptic abnormalities associated with impaired neuromuscular transmission in a group of patients with \u2018limb-girdle myasthenia\u2019","volume":"129","author":"Slater","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.01.001_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0896-6273(89)90029-9","article-title":"Distribution of Na+ channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43\u00a0kD protein","volume":"3","author":"Flucher","year":"1989","journal-title":"Neuron"},{"key":"10.1016\/j.ncl.2018.01.001_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/mus.880090803","article-title":"Ionic channels: I. The biophysical basis for ion passage and channel gating","volume":"9","author":"Ruff","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.001_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mus.880090902","article-title":"Ionic channels II. Voltage- and agonist-gated and agonist-modified channel properties and structure","volume":"9","author":"Ruff","year":"1986","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.001_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1113\/jphysiol.1975.sp010821","article-title":"The distribution of acetylcholine sensitivity at the post-synaptic membrane of vertebrate skeletal twitch muscles: iontophoretic mapping in the micron range","volume":"244","author":"Kuffler","year":"1975","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/317066a0","article-title":"Concentration of acetylcholine receptor mRNA in synaptic regions of adult muscle fibers","volume":"317","author":"Merlie","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2018.01.001_bib40","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1242\/dev.113.4.1181","article-title":"Selective expression of an acetylcholine receptor-lacZ transgene in synaptic nuclei of adult muscle fibers","volume":"113","author":"Sanes","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.ncl.2018.01.001_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0301-0082(85)90018-8","article-title":"Nicotinic acetylcholine receptors in vertebrate muscle: properties, distribution and neural control","volume":"25","author":"Salpeter","year":"1985","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.850793","article-title":"Myasthenic immunoglobulin accelerates acetylcholine receptor degradation","volume":"196","author":"Kao","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.ncl.2018.01.001_bib43","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1016\/S0021-9258(18)50365-3","article-title":"Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies","volume":"254","author":"Merlie","year":"1979","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ncl.2018.01.001_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/321063a0","article-title":"Fluorescently labeled Na+ channels are localized and immobilized to synapses of innervated muscle fibres","volume":"321","author":"Angelides","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2018.01.001_bib45","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/BF01188407","article-title":"Localization of voltage-sensitive sodium channels on the extrasynaptic membrane surface of mouse skeletal muscle by autoradiography of scorpion toxin binding sites","volume":"19","author":"Le Teut","year":"1990","journal-title":"J\u00a0Neurocytol"},{"key":"10.1016\/j.ncl.2018.01.001_bib46","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1523\/JNEUROSCI.07-09-02957.1987","article-title":"Localization of sodium channel subtypes in rat skeletal muscle using channel-specific monoclonal antibodies","volume":"7","author":"Haimovich","year":"1987","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ncl.2018.01.001_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1987.sp016611","article-title":"Sodium channels near end-plates and nuclei of snake skeletal muscle","volume":"388","author":"Roberts","year":"1987","journal-title":"J\u00a0Physiol"},{"issue":"1 Pt 1","key":"10.1016\/j.ncl.2018.01.001_bib48","doi-asserted-by":"crossref","first-page":"C229","DOI":"10.1152\/ajpcell.1992.262.1.C229","article-title":"Na current density at and away from end plates on rat fast- and slow-twitch skeletal muscle fibers","volume":"262","author":"Ruff","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1113\/jphysiol.1992.sp019407","article-title":"Na+ current densities and voltage dependence in human intercostal muscle fibres","volume":"458","author":"Ruff","year":"1992","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib50","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/mus.880160906","article-title":"Na+ currents near and away from endplates on human fast and slow twitch muscle fibers","volume":"16","author":"Ruff","year":"1993","journal-title":"Muscle Nerve"},{"issue":"1 Pt 1","key":"10.1016\/j.ncl.2018.01.001_bib51","doi-asserted-by":"crossref","first-page":"C171","DOI":"10.1152\/ajpcell.1993.265.1.C171","article-title":"Comparison of Na+ currents from type IIa and IIb human intercostal muscle fibers","volume":"265","author":"Ruff","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib52","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1073\/pnas.88.17.7669","article-title":"Acetylcholine receptor-inducing activity stimulates expression of the epsilon-subunit gene of the muscle acetylcholine receptor","volume":"88","author":"Martinou","year":"1991","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2018.01.001_bib53","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1084::AID-MUS2>3.0.CO;2-W","article-title":"Effects of length changes on Na+ current amplitude and excitability near and far from the end-plate","volume":"19","author":"Ruff","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.001_bib54","series-title":"Nerve muscle and synapse","author":"Katz","year":"1966"},{"key":"10.1016\/j.ncl.2018.01.001_bib55","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1085\/jgp.87.6.907","article-title":"Sodium channel distribution in vertebrate skeletal muscle","volume":"87","author":"Caldwell","year":"1986","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3940(92)90131-P","article-title":"Fast and slow twitch skeletal muscle fibres differ in their distributions of Na channels near the endplate","volume":"135","author":"Milton","year":"1992","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.ncl.2018.01.001_bib58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1749-6632.1966.tb45504.x","article-title":"Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications","volume":"135","author":"Strauss","year":"1966","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib59","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1749-6632.1965.tb18999.x","article-title":"Immunological concomitants of myasthenia gravis","volume":"124","author":"Strauss","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ncl.2018.01.001_bib61","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2018.01.001_bib62","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1196\/annals.1254.036","article-title":"Autoantibodies in myasthenia gravis and related disorders","volume":"998","author":"Vincent","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 7","key":"10.1016\/j.ncl.2018.01.001_bib63","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.001_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2014.05.037","article-title":"Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population","volume":"342","author":"Chang","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"issue":"9","key":"10.1016\/j.ncl.2018.01.001_bib65","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2016.2032","article-title":"Clinical characteristics of patients with double-seronegative myasthenia gravis and antibodies to cortactin","volume":"73","author":"Cort\u00e9s-Vicente","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib66","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/jmbi.1996.0187","article-title":"Projection structure of the nicotinic acetylcholine receptor: distinct conformations of the \u03b1 subunits","volume":"257","author":"Unwin","year":"1996","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ncl.2018.01.001_bib67","doi-asserted-by":"crossref","first-page":"8805","DOI":"10.1073\/pnas.82.24.8805","article-title":"Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies","volume":"82","author":"Lennon","year":"1985","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(00)01980-3","article-title":"The conformation of the main immunogenic region on the alpha-subunit of muscle acetylcholine receptor is affected by neighboring receptor subunits","volume":"481","author":"Fostieri","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ncl.2018.01.001_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ncl.2018.01.001_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/WNL.27.4.307","article-title":"Ultrastructural localization of the acetylcholine receptors in myasthenia gravis and in its experimental autoimmune model","volume":"27","author":"Engel","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.001_bib71","first-page":"197","article-title":"Mechanisms of acetylcholine receptor loss from the neuromuscular junction","volume":"90","author":"Engel","year":"1982","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.ncl.2018.01.001_bib72","first-page":"40","article-title":"Structure and kinetic properties of the acetylcholine receptor","volume":"vol. 56","author":"Kaminski","year":"1999"},{"key":"10.1016\/j.ncl.2018.01.001_bib73","series-title":"Myology","first-page":"1769","article-title":"Acquired autoimmune myasthenia gravis","author":"Engel","year":"1994"},{"key":"10.1016\/j.ncl.2018.01.001_bib74","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1084\/jem.144.3.726","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ncl.2018.01.001_bib75","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.144.3.739","article-title":"Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies","volume":"144","author":"Lindstrom","year":"1976","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ncl.2018.01.001_bib76","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/285238a0","article-title":"Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors","volume":"285","author":"Lennon","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ncl.2018.01.001_bib77","first-page":"565","article-title":"The myasthenic syndromes","volume":"vol. 1","author":"Kaminski","year":"1996"},{"key":"10.1016\/j.ncl.2018.01.001_bib78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.1971.tb30741.x","article-title":"Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and the myasthenic syndrome","volume":"183","author":"Engel","year":"1971","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib79","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.22.1.71","article-title":"Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis","volume":"22","author":"Santa","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.001_bib80","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1749-6632.1976.tb47676.x","article-title":"The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study","volume":"274","author":"Engel","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib81","first-page":"267","article-title":"Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis. Ultrastructure and light microscopic localization and electrophysiological correlations","volume":"52","author":"Engel","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ncl.2018.01.001_bib82","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.29.2.179","article-title":"Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor","volume":"29","author":"Engel","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.001_bib83","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.147.4.973","article-title":"Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis","volume":"147","author":"Lennon","year":"1978","journal-title":"J\u00a0Exp Med"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.001_bib84","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.4049\/jimmunol.179.12.8562","article-title":"Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis","volume":"179","author":"Zhou","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.001_bib85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21536","article-title":"Novel complement inhibitor limits severity of experimentally induced myasthenia gravis","volume":"65","author":"Soltys","year":"2009","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.001_bib86","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/mus.24057","article-title":"Targeting therapy to the neuromuscular junction: proof of concept","volume":"49","author":"Kusner","year":"2014","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib87","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/mus.25529","article-title":"QMG and MG-ADL correlations: study of eculizumab treatment of myasthenia gravis","volume":"56","author":"Howard","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.001_bib88","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis (REGAIN): a phse 3, randomized, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib89","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1212\/WNL.41.9.1497","article-title":"Inflammation at the neuromuscular junction in myasthenia gravis","volume":"41","author":"Maselli","year":"1991","journal-title":"Neurology"},{"issue":"8473","key":"10.1016\/j.ncl.2018.01.001_bib90","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.001_bib91","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ncl.2018.01.001_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.expneurol.2014.12.013","article-title":"Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis","volume":"270","author":"Phillips","year":"2015","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib93","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2015.01.007","article-title":"Electrophysiological analysis of neuromuscular synaptic function in myasthenia gravis patients and animal models","volume":"270","author":"Plomp","year":"2015","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib94","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/CND.0b013e318275197c","article-title":"Different characteristic phenotypes according to antibody in myasthenia gravis","volume":"14","author":"Oh","year":"2012","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.ncl.2018.01.001_bib95","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.001_bib96","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.001_bib97","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib98","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1212\/01.WNL.0000065882.63904.53","article-title":"Clinical aspects of MuSK antibody positive seronegative MG","volume":"60","author":"Sanders","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2018.01.001_bib99","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/ene.13300","article-title":"Multiple antibody detection in 'seronegative' myasthenia gravis patients","volume":"24","author":"Hong","year":"2017","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.001_bib100","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib101","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","article-title":"Treatment of MuSK-associated myasthenia gravis","volume":"16","author":"El-Salem","year":"2014","journal-title":"Curr Treat Options Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib102","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3988\/jcn.2014.10.2.119","article-title":"Clinical and electrophysiologic responses to acetylcholinesterase inhibitors in MuSK-antibody-positive myasthenia gravis: evidence for cholinergic neuromuscular hyperactivity","volume":"10","author":"Shin","year":"2014","journal-title":"J\u00a0Clin Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.001_bib103","first-page":"1473","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib104","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06808.x","article-title":"Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis","volume":"1275","author":"Plomp","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2016.11.005","article-title":"IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients","volume":"77","author":"Koneczny","year":"2017","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib106","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneurol.2011.2200","article-title":"Acute severe animal model of anti\u2013muscle-specific kinase myasthenia combined postsynaptic and presynaptic changes","volume":"69","author":"Richman","year":"2012","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib107","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol"},{"issue":"51","key":"10.1016\/j.ncl.2018.01.001_bib108","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.001_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.12.005","article-title":"Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis","volume":"244","author":"Mori","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ncl.2018.01.001_bib110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000330031","article-title":"Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients","volume":"20","author":"T\u00fcz\u00fcn","year":"2011","journal-title":"Med Princ Pract"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib111","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib112","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.001_bib113","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1038\/srep13928","article-title":"Collagen Q and anti-MuSK autoantibody competitively suppress agrin\/LRP4\/MuSK signaling","volume":"10","author":"Otsuka","year":"2015","journal-title":"Sci Rep"},{"issue":"Pt. B","key":"10.1016\/j.ncl.2018.01.001_bib114","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cbi.2016.04.019","article-title":"Roles of collagen Q in MuSK antibody-positive myasthenia gravis","volume":"259","author":"Ohno","year":"2016","journal-title":"Chem Biol Interact"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.mcn.2011.12.007","article-title":"The formation of complex acetylcholine receptor clusters requires MuSK kinase activity and structural information from the MuSK extracellular domain","volume":"49","author":"Mazhar","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.ncl.2018.01.001_bib116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.nmd.2013.08.002","article-title":"Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MuSK","volume":"24","author":"Gallenm\u00fcller","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.001_bib117","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.410370513","article-title":"Acetylcholine release in myasthenia gravis: regulation at single end-plate level","volume":"37","author":"Plomp","year":"1995","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.001_bib118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2011.12.016","article-title":"Neurophysiological characteristics of MuSK antibody positive myasthenia gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors","volume":"316","author":"Chroni","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"issue":"12","key":"10.1016\/j.ncl.2018.01.001_bib119","doi-asserted-by":"crossref","first-page":"e110571","DOI":"10.1371\/journal.pone.0110571","article-title":"Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.01.001_bib120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2012.02.010","article-title":"3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis","volume":"245","author":"Mori","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"issue":"10","key":"10.1016\/j.ncl.2018.01.001_bib121","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J\u00a0Physiol"},{"issue":"2","key":"10.1016\/j.ncl.2018.01.001_bib122","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.001_bib123","first-page":"427","article-title":"Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis","volume":"259","author":"Pevzner","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib124","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archneurol.2011.2393","article-title":"Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis","volume":"69","author":"Zhang","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A\u00a0comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"5","key":"10.1016\/j.ncl.2018.01.001_bib126","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/mus.25591","article-title":"Anti-LRP4 autoantibodies in Chinese patients with myasthenia gravis","volume":"56","author":"Li","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2018.01.001_bib127","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.ncl.2018.01.001_bib128","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.nmd.2013.03.013","article-title":"Double seronegative myasthenia gravis with anti-LRP 4 antibodies","volume":"23","author":"Zouvelou","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ncl.2018.01.001_bib129","first-page":"1","article-title":"Immunization with recombinantly expressed LRP4 induces experimental autoimmune myasthenia gravis in C57BL\/6 mice","volume":"4","author":"Ulusoy","year":"2017","journal-title":"Immunol Invest"},{"issue":"1","key":"10.1016\/j.ncl.2018.01.001_bib130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuron.2012.04.033","article-title":"Distinct roles of muscle and motoneuron LRP4 in neuromuscular junction formation","volume":"75","author":"Wu","year":"2012","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.ncl.2018.01.001_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040896","article-title":"Synaptic homeostasis and its immunological disturbance in neuromuscular junction disorders","volume":"18","author":"Takamori","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib132","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nature11348","article-title":"Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses","volume":"489","author":"Yumoto","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ncl.2018.01.001_bib133","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/jamaneurol.2015.0853","article-title":"Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia","volume":"72","author":"Selcen","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.01.001_bib134","doi-asserted-by":"crossref","first-page":"e91816","DOI":"10.1371\/journal.pone.0091816","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.ncl.2018.01.001_bib135","doi-asserted-by":"crossref","first-page":"18373","DOI":"10.1073\/pnas.0910391106","article-title":"Podosomes are present in a postsynaptic apparatus and participate in its maturation","volume":"106","author":"Proszynski","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.ncl.2018.01.001_bib136","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.autrev.2014.08.039","article-title":"Cortactin autoantibodies in myasthenia gravis","volume":"13","author":"Gallardo","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.ncl.2018.01.001_bib137","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.ajpath.2016.05.025","article-title":"Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis","volume":"186","author":"Gomez","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ncl.2018.01.001_bib138","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jns.2014.12.015","article-title":"Collagen Q\u2013a potential target for autoantibodies in myasthenia gravis","volume":"348","author":"Zoltowska Katarzyna","year":"2015","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2018.01.001_bib139","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.57.11.1596","article-title":"The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies","volume":"57","author":"Romi","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-5728(00)00394-5","article-title":"Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations","volume":"111","author":"Romi","year":"2000","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ncl.2018.01.001_bib141","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2018.01.001_bib142","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/eci.12.34","article-title":"Muscle autoantibodies in myasthenia gravis: beyond diagnosis?","volume":"8","author":"Meriggioli","year":"2012","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386191830001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386191830001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T01:53:41Z","timestamp":1660874021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386191830001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":142,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S073386191830001X"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2018.01.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nature and Action of Antibodies in Myasthenia Gravis","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2018.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}